Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus: A Systematic Review of Clinical Practice Guidelines
Tóm tắt
Management of systemic lupus erythematosus (SLE) is complex and variability in practices exists. Guidelines have been developed to help improve the management of SLE patients, but there has been no formal evaluation of these guidelines. This study aims to compare the scope, quality, and consistency of clinical practice guidelines on the diagnosis, monitoring, and treatment of patients with SLE.
Electronic databases were searched up to April 2014. The Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument and textual synthesis was used to appraise and compare recommendations.
Nine clinical practice guidelines and 5 consensus statements were identified, which covered 7 topics: diagnosis, monitoring, treatment, neuropsychiatric SLE, lupus nephritis, antiphospholipid syndrome, and other manifestations of lupus. The methodological quality of the guidelines was variable, with the overall mean AGREE II scores ranging from 31% to 75%, out of a maximum 100%. Scores were consistently low for applicability, with only 1 guideline scoring above 50%. There was substantial variability in the treatments recommended for class II and V lupus nephritis, the recommended duration of maintenance therapy for class III/IV lupus nephritis (from 1 to 4 years), and timing of ophthalmologic examination for patients taking corticosteroids.
Published guidelines on SLE cover a complex area of clinical care, but the methodological quality, scope, and recommendations varied substantially. Collaborative and multidisciplinary efforts to develop comprehensive, high‐quality evidence‐based guidelines are needed to promote best treatment and health outcomes for patients with SLE.
Từ khóa
Tài liệu tham khảo
Siedner MJ, 2007, Screening for proteinuria in patients with lupus: a survey of practice preferences among American rheumatologists, J Rheumatol, 34, 973
Brunner H, 2009, Corticosteroid use in childhood‐onset systemic lupus erythematosus‐practice patterns at four pediatric rheumatology centers, Clin Exp Rheumatol, 27, 155
Ruiz IG, 2012, Diagnosis and treatment of lupus nephritis: consensus document from the systemic auto‐immune disease group (GEAS) of the Spanish Society of Internal Medicine (SEMI) and Spanish Society of Nephrology (SEN), Nefrologia, 32, 1
Tellingen A, 2012, Dutch guidelines for diagnosis and therapy of proliferative lupus nephritis, Neth J Med, 70, 199
Kidney Disease Improving Global Outcomes Work Group, 2012, KDIGO clinical practice guideline for glomerulonephritis, Kidney Int Suppl, 2, 139
Grol R., 2001, Successes and failures in the implementation of evidence‐based guidelines for clinical practice, Med Care, 39, II46
Nilsen E, 2006, Methods of consumer involvement in developing healthcare policy and research, clinical practice guidelines and patient information material, Cochrane Database Syst Rev, 3, CD004563
Henderson L, 2012, Treatment for lupus nephritis, Cochrane Database Syst Rev, 12, CD002922
Costedoat‐ChalumeauN.International prospective study on adherence to treatment in patients with active systemic lupus erythematosus (TPASLE). 2011. URL:http://clinicaltrials.gov/show/NCT01509989.
Nieuwlaat R, 2014, Interventions for enhancing medication adherence, Cochrane Database Syst Rev, 11, CD000011